40
ASCENDIA PHARMACEUTICALS, INC. raises $4.1M under Reg D
Company raise · Closed · Offering $4.1M · Sold $4.1M · NORTH BRUNSWICK, NJ · filed 2026-07-24
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
| James Gale | Director |
| Shoufeng Li | Director |
| Jingjun Huang | Executive Officer, Director |
| Robert Bloder | Director |
| Theron Odlaug | Director |
Signed by Dr. Jingjun Huang, President and CEO.
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.